Picture of Psyence logo

PSYG Psyence Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Psyence, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

2020
December 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M10 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.093-11.3-4.6-6.08-69.4
Depreciation
Non-Cash Items-0.039.170.9550.40664.9
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.076-0.1170.0331.94-0.487
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-0.046-2.2-3.56-3.64-4.92
Capital Expenditures-0.376-0.164-0.264-0.988
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.004-0.147-0.166-0.002
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.373-0.311-0.43-0.99
Financing Cash Flow Items0.03-0.0340
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.038.671.272.964.58
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.0166.1-2.6-1.11-1.32